DCPG - CAS 201730-11-2
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C10H9NO6
Molecular Weight:
239.18
COA:
Inquire
Targets:
mGluR
Description:
DCPG is a potent and selective mGlu8a agonist (EC50 = 31 nM) displaying > 100-fold selectivity over mGlu1-7. It increases c-Fos expression in stress-related brain areas following systemic administration in mice in vivo.
Brife Description:
mGlu8a agonist
Purity:
≥98% by HPLC
Synonyms:
(S)-3,4-DCPG; (S)-3,4-Dicarboxyphenylglycine; 4-[Amino(carboxy)methyl]phthalic acid
MSDS:
Inquire
InChIKey:
IJVMOGKBEVRBPP-ZETCQYMHSA-N
InChI:
InChI=1S/C10H9NO6/c11-7(10(16)17)4-1-2-5(8(12)13)6(3-4)9(14)15/h1-3,7H,11H2,(H,12,13)(H,14,15)(H,16,17)/t7-/m0/s1
Canonical SMILES:
C1=CC(=C(C=C1C(C(=O)O)N)C(=O)O)C(=O)O
1.The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease.
Johnson KA1, Jones CK, Tantawy MN, Bubser M, Marvanova M, Ansari MS, Baldwin RM, Conn PJ, Niswender CM. Neuropharmacology. 2013 Mar;66:187-95. doi: 10.1016/j.neuropharm.2012.03.029. Epub 2012 Apr 21.
Metabotropic glutamate receptors (mGlus) are 7 Transmembrane Spanning Receptors (7TMs) that are differentially expressed throughout the brain and modulate synaptic transmission at both excitatory and inhibitory synapses. Recently, mGlus have been implicated as therapeutic targets for many disorders of the central nervous system, including Parkinson's disease (PD). Previous studies have shown that nonselective agonists of group III mGlus have antiparkinsonian effects in several animal models of PD, suggesting that these receptors represent promising targets for treating the motor symptoms of PD. However, the relative contributions of different group III mGlu subtypes to these effects have not been fully elucidated. Here we report that intracerebroventricular (icv) administration of the mGlu(8)-selective agonist (S)-3,4-dicarboxyphenylglycine (DCPG [ 2.5, 10, or 30 nmol]) does not alleviate motor deficits caused by acute (2 h) treatment with haloperidol or reserpine.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related mGluR Products


CAS 856702-40-4 CBiPES hydrochloride

CBiPES hydrochloride
(CAS: 856702-40-4)

CBiPES hydrochloride is a selective positive allosteric modulator of the mGlu2 receptor (IC50 = 98.2 nM).

CAS 120667-15-4 (RS)-PPG

(RS)-PPG
(CAS: 120667-15-4)

(RS)-PPG is a potent and selective group III metabotropic glutamate receptor (mGluR) agonist, with approximately 25-fold selectivity for hmGlu8. (RS)-PPG exhibi...

CAS 103439-17-4 Z-Cyclopentyl-AP4

Z-Cyclopentyl-AP4
(CAS: 103439-17-4)

Z-Cyclopentyl-AP4 is a group III mGlu receptor agonist with higher potency at mGlu4 than mGlu8 (EC50 = 49 and 124 μM, respectively). Z-Cyclopentyl-AP4 selective...

CAS 1445605-23-1 Lu AF21934

Lu AF21934
(CAS: 1445605-23-1)

Lu AF21934 is a selective and brain-penetrating positive allosteric modulator (PAM) of mGlu4 receptors (IC50= 500 nM) on the harmaline-induced tremor and other ...

CAS 338736-46-2 LY 456236 hydrochloride

LY 456236 hydrochloride
(CAS: 338736-46-2)

LY 456236 hydrochloride is a mGlu1 receptor antagonist with IC50 value of 143 nM. It may be used in the treatment of chronic pain.

CAS 635318-11-5 LY404039

LY404039
(CAS: 635318-11-5)

LY-404,039, also known as pomaglumetad, is an amino acid analog drug that acts as a highly selective agonist for the metabotropic glutamate receptor group II su...

CAS 169209-64-7 MSPG

MSPG
(CAS: 169209-64-7)

MSPG is a non-selective antagonist of presynaptic mGluRs.

CAS 23052-81-5 L-AP4

L-AP4
(CAS: 23052-81-5)

L-AP4 is a selective group III metabotropic glutamate receptor (mGluR) agonist. It also acts as an agonist at the quisqualate-sensitized AP6 site in hippocampus...

Chemical Structure

CAS 201730-11-2 DCPG

Quick Inquiry

Verification code

Featured Items